Draft Guidance Drills Down With Details To Cut Pediatric Acetaminophen Overdose Risk
This article was originally published in The Tan Sheet
Executive Summary
FDA suggests new and repeats previous recommendations to reduce the risk of pediatric overdose with acetaminophen products due either to unsupervised ingestion or therapeutic errors. The guidance includes greater detail on delivery devices and labeling information for pediatric acetaminophen OTCs.
You may also be interested in...
Flow Restrictors Limit Children’s Access To Drugs; Standards Needed
Only 6% of children emptied medicine bottles with flow restrictors in 10 minutes, compared to 82% who emptied bottles with incompletely closed child-resistant caps within two minutes, a CDC study shows. But researchers and stakeholders suggest waiting for industry standards to implement flow restrictors.
Campaign Targets Unsupervised Pediatric Drug Ingestion
The Consumer Healthcare Products Association, the Centers for Disease Control and Prevention and a public-private safe-medication initiative launch the “Up and Away and Out of Sight” campaign to educate caregivers about how to stop curious children from consuming drugs without supervision.
Acetaminophen Panel Recommends Standardizing Solid Dose Strength
A joint advisory panel recommended FDA consider standardizing chewable children's acetaminophen products to one strength.